Literature DB >> 33567718

The Indices of Cardiovascular Magnetic Resonance Derived Atrial Dynamics May Improve the Contemporary Risk Stratification Algorithms in Children with Hypertrophic Cardiomyopathy.

Lidia Ziółkowska1, Łukasz Mazurkiewicz2, Joanna Petryka3, Monika Kowalczyk-Domagała1, Agnieszka Boruc1, Katarzyna Bieganowska1, Elżbieta Ciara4, Dorota Piekutowska-Abramczuk4, Mateusz Śpiewak5, Jolanta Miśko5, Magdalena Marczak5, Grażyna Brzezińska-Rajszys1.   

Abstract

INTRODUCTION: The most efficient risk stratification algorithms are expected to deliver robust and indefectible identification of high-risk children with hypertrophic cardiomyopathy (HCM). Here we compare algorithms for risk stratification in primary prevention in HCM children and investigate whether novel indices of biatrial performance improve these algorithms. METHODS AND
RESULTS: The endpoints were defined as sudden cardiac death, resuscitated cardiac arrest, or appropriate implantable cardioverter-defibrillator discharge. We examined the prognostic utility of classic American College of Cardiology/American Heart Association (ACC/AHA) risk factors, the novel HCM Risk-Kids score and the combination of these with indices of biatrial dynamics. The study consisted of 55 HCM children (mean age 12.5 ± 4.6 years, 69.1% males); seven had endpoints (four deaths, three appropriate ICD discharges). A strong trend (DeLong p = 0.08) was observed towards better endpoint identification performance of the HCM Risk-Kids Model compared to the ACC/AHA strategy. Adding the atrial conduit function component significantly improved the prediction capabilities of the AHA/ACC Model (DeLong p = 0.01) and HCM Risk-Kids algorithm (DeLong p = 0.04).
CONCLUSIONS: The new HCM Risk-Kids individualised algorithm and score was capable of identifying high-risk children with very good accuracy. The inclusion of one of the atrial dynamic indices improved both risk stratification strategies.

Entities:  

Keywords:  atrial strain; hypertrophic cardiomyopathy; outcome; risk markers

Year:  2021        PMID: 33567718      PMCID: PMC7915130          DOI: 10.3390/jcm10040650

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  34 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Right atrial and ventricular adaptation to chronic right ventricular pressure overload.

Authors:  Sydney L Gaynor; Hersh S Maniar; Jeffrey B Bloch; Paul Steendijk; Marc R Moon
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

3.  Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

Authors:  Martin S Maron; Ethan J Rowin; Benjamin S Wessler; Paula J Mooney; Amber Fatima; Parth Patel; Benjamin C Koethe; Mikhail Romashko; Mark S Link; Barry J Maron
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676

4.  Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).

Authors:  Stefano Nistri; Iacopo Olivotto; Sandro Betocchi; Maria Angela Losi; Grazia Valsecchi; Bruno Pinamonti; Maria Rosa Conte; Franco Casazza; Maurizio Galderisi; Barry J Maron; Franco Cecchi
Journal:  Am J Cardiol       Date:  2006-08-14       Impact factor: 2.778

5.  Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function.

Authors:  Yasuhiko Takemoto; Marion E Barnes; James B Seward; Steven J Lester; Christopher A Appleton; Bernard J Gersh; Kent R Bailey; Teresa S M Tsang
Journal:  Am J Cardiol       Date:  2005-09-15       Impact factor: 2.778

6.  Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.

Authors:  Mohammadali Habibi; Joao A C Lima; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; Kotaro Fukumoto; David Spragg; Hiroshi Ashikaga; John Rickard; Joseph E Marine; Hugh Calkins; Saman Nazarian
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

7.  Determinant of left atrial dilation in patients with hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study.

Authors:  Fabrice Bauer; Takahiro Shiota; Richard D White; Harry M Lever; Jian Xin Qin; Jeannie Drinko; Maureen Martin; Hiroyuki Tsujino; Marta Sitges; Yong Jin Kim; James D Thomas
Journal:  J Am Soc Echocardiogr       Date:  2004-09       Impact factor: 5.251

8.  Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy.

Authors:  Woo-In Yang; Chi Young Shim; Young Jin Kim; Sung-Ai Kim; Sang Jae Rhee; Eui-Young Choi; Donghoon Choi; Yangsoo Jang; Namsik Chung; Seung-Yun Cho; Jong-Won Ha
Journal:  J Am Soc Echocardiogr       Date:  2009-10-30       Impact factor: 5.251

9.  Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Michael J Ackerman; Susan A Casey; Christopher Semsarian; N A Mark Estes; Kevin M Shannon; Euan A Ashley; Sharlene M Day; Giuseppe Pacileo; Francesco Formisano; Emmanuela Devoto; Aristidis Anastasakis; J Martijn Bos; Anna Woo; Camillo Autore; Robert H Pass; Giuseppe Boriani; Ross F Garberich; Adrian K Almquist; Mark W Russell; Luca Boni; Stuart Berger; Martin S Maron; Mark S Link
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094

10.  Biatrial performance in children with hypertrophic cardiomyopathy: CMR study.

Authors:  Łukasz Mazurkiewicz; Lidia Ziółkowska; Joanna Petryka; Mateusz Śpiewak; Łukasz Małek; Agata Kubik; Magdalena Marczak; Jolanta Misko; Grażyna Brzezińska-Rajszys
Journal:  Eur Radiol       Date:  2018-06-07       Impact factor: 5.315

View more
  2 in total

1.  Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study.

Authors:  Magdalena Stachera; Paweł Przybyło; Katarzyna Sznajder; Marek Gierlotka
Journal:  Diagnostics (Basel)       Date:  2022-04-28

Review 2.  What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?

Authors:  Ingegerd Östman-Smith
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.